245 related articles for article (PubMed ID: 36705371)
1. Optical coherence tomography classifications of diabetic macular edema and response to aflibercept: One-year follow-up outcomes in a Chinese population.
Gu Z; Xi T; Zhang C; Yang G
Medicine (Baltimore); 2023 Jan; 102(4):e32815. PubMed ID: 36705371
[TBL] [Abstract][Full Text] [Related]
2. Effect of Optical Coherence Tomography Patterns on One-year Outcomes of Aflibercept Therapy for Diabetic Macular Edema.
Ozcaliskan S; Balci S; Karasu B; Artunay O
J Coll Physicians Surg Pak; 2020 Feb; 30(2):149-153. PubMed ID: 32036821
[TBL] [Abstract][Full Text] [Related]
3. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
Kim M; Lee P; Kim Y; Yu SY; Kwak HW
Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of anti-vascular endothelial growth factor on diabetic macular edema diagnosed with different patterns of optical coherence tomography: A network meta-analysis.
Yao J; Huang W; Gao L; Liu Y; Zhang Q; He J; Zhang L
PLoS One; 2024; 19(6):e0304283. PubMed ID: 38848379
[TBL] [Abstract][Full Text] [Related]
7. Subfoveal choroidal thickness changes after intravitreal ranibizumab injections in different patterns of diabetic macular edema using a deep learning-based auto-segmentation.
Wang XN; Cai X; He S; Zhang X; Wu Q
Int Ophthalmol; 2023 Dec; 43(12):4399-4407. PubMed ID: 33783677
[TBL] [Abstract][Full Text] [Related]
8. CORRELATION OF OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI WITH VISUAL OUTCOMES IN DIFFERENT PATTERNS OF DIABETIC MACULAR EDEMA.
Kang JW; Chung H; Chan Kim H
Retina; 2016 Sep; 36(9):1630-9. PubMed ID: 26900741
[TBL] [Abstract][Full Text] [Related]
9. A Comparison Study of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment.
Kaldırım H; Yazgan S; Kırgız A; Atalay K; Savur F
Curr Eye Res; 2019 Sep; 44(9):987-993. PubMed ID: 30983426
[No Abstract] [Full Text] [Related]
10. Evaluation of the efficacy of anti-vascular endothelial growth factors in diabetic macular edema with retinal inner and outer layers disorganization.
Kocapınar Y; Kaplan FB; Demirciler Sönmez A; Açıkalın B
Acta Diabetol; 2023 Oct; 60(10):1391-1398. PubMed ID: 37378699
[TBL] [Abstract][Full Text] [Related]
11. Ranibizumab versus aflibercept for diabetic macular edema: 18-month results of a comparative, prospective, randomized study and multivariate analysis of visual outcome predictors.
Chatzirallis A; Theodossiadis P; Droutsas K; Koutsandrea C; Ladas I; Moschos MM
Cutan Ocul Toxicol; 2020 Dec; 39(4):317-322. PubMed ID: 32722955
[TBL] [Abstract][Full Text] [Related]
12. Functional and anatomic results of up to 24 months aflibercept treatment for diabetic macular edema in real-life setting.
Tsapardoni FN; Makri OE; Lagogiannis AP; Tsekouras IK; Chairas N; Pallikari A; Pagoulatos DD; Georgakopoulos CD
Hell J Nucl Med; 2019; 22 Suppl 2():47-54. PubMed ID: 31802045
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the short-term effect of aflibercept and dexamethasone implant on serous retinal detachment in the treatment of naive diabetic macular edema.
Bolukbasi S; Cakir A; Erden B; Karaca G
Cutan Ocul Toxicol; 2019 Dec; 38(4):401-405. PubMed ID: 31438736
[No Abstract] [Full Text] [Related]
14. Prediction of anti-VEGF efficacy in diabetic macular oedema using intraocular cytokines and macular optical coherence tomography.
Mao J; Zhang S; Zheng Z; Deng X; Liu C; Chen Y; Zhao S; Zhang Y; Shen L
Acta Ophthalmol; 2022 Jun; 100(4):e891-e898. PubMed ID: 34403203
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the effect of vitreomacular interface abnormalities on anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema by optical coherence tomography: A systematic review and meta-analysis.
Gong Y; Wang M; Li Q; Shao Y; Li X
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103555. PubMed ID: 37088331
[TBL] [Abstract][Full Text] [Related]
16. Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.
Dărăbuș DM; Pac CP; Roşca C; Munteanu M
Rom J Ophthalmol; 2023; 67(3):312-324. PubMed ID: 37876516
[No Abstract] [Full Text] [Related]
17. VISUAL AND MORPHOLOGIC OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR DIABETIC MACULAR EDEMA BASED ON OPTICAL COHERENCE TOMOGRAPHY PATTERNS.
Seo KH; Yu SY; Kim M; Kwak HW
Retina; 2016 Mar; 36(3):588-95. PubMed ID: 26398695
[TBL] [Abstract][Full Text] [Related]
18. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
Ozsaygili C; Duru N
Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study.
Isik P; Sizmaz S; Esen E; Uysal A; Demircan N
Int Ophthalmol; 2023 Nov; 43(11):4171-4180. PubMed ID: 37505290
[TBL] [Abstract][Full Text] [Related]
20. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
